News and Media

26 Sep

Study Shows How Chinese Medicine Kills Cancer Cells

Researchers at the University of Adelaide have shown how a complex mix of plant compounds derived from ancient clinical practice in China – a Traditional Chinese Medicine – works to kill cancer cells. Compound kushen injection (CKI) is approved for use in China to treat various cancer tumours, usually as an adjunct to western chemotherapy

Read More
26 Sep

‘The Pill’ to Thank for Drop in Ovarian Cancer Deaths

A worldwide decline in deaths from ovarian cancer has been credited to oral contraceptives in a new global study. Researchers found that, in many countries, decreases in ovarian cancer matched up with increased use of the pill, although a decline in hormone replacement therapy may also be a factor. Both Australia and New Zealand have

Read More
26 Sep

Researchers Identify Genetic Key to More Precise Cancer Treatment

International research has found some patients with oesophageal cancer should receive a combination of treatments, due to multiple genetic changes or mutations contributing to their disease. The University of Queensland and QIMR Berghofer Medical Research Institute collaborated on the study led byCancer Research UK and the International Cancer Genome Consortium. The study identified three distinct

Read More
25 Sep

Young People with Cancer Should Have Affordable Options to Preserve Their Fertility

Authors Antoinette Anazodo Conjoint Senior Lecturer, UNSW Australia Brigitte Gerstl International Manager FUTuRE Fertility, Sydney Children’s Hospital, UNSW Australia Options for females International clinical practice guidelines recommend a number of fertility-preservation techniques for cancer patients. In adolescent females (those who have reached puberty), there is oocyte cryopreservation (egg collection and storage) and embryo cryopreservation (fertilisation of

Read More
25 Sep

Detecting Pancreatic Cancer Early in New Type 2 Diabetes Patients

New research presented at this year’s European Association for the Study of Diabetes (EASD) meeting in Munich, Germany (12-16 September) suggests that screening patients newly diagnosed with diabetes for pancreatic cancer could be an effective way of diagnosing and treating pancreatic cancer early. The study is by Dr Pavel Škrha, Charles University, Prague, Czech Republic

Read More
14 Sep

DHHS to Pilot Collection of Patient Reported Outcome Measures

The Victorian Department of Health and Human Services has announced that it will pilot the collection of Patient Reported Outcome Measures (PROMs) from health services and hospitals from 1 July 2017. PROMs are data obtained from structured surveys of patients about their assessment of their health outcomes. They differ from data obtained from patient experience

Read More
09 Sep

Breakthrough Heralds Hope for Advanced Bladder Cancer Patients

Researchers at Hudson Institute of Medical Research have discovered a crucial genetic marker that heralds better treatment and outcomes for patients with advanced bladder cancer. The world-first finding recently published in the prestigious journal, Molecular Cancer Therapeutics may represent the first major progress in treatment for advanced bladder cancer patients in thirty years. Each year

Read More
02 Sep

Key Differences in Tumours Could Help Tackle Ovarian Cancer Recurrence

A new study by Hudson Institute of Medical Research and Fiona Elsey Cancer Research Institute scientists has uncovered important differences between pre- and post- chemotherapy ovarian cancer tumours that may be used to better tackle chemotherapy resistance. The findings of the study, led by Professor Nuzhat Ahmed, Hudson Institute of Medical Research and Fiona Elsey

Read More
02 Sep

Cell Therapies Platform and Miltenyi Biotec Cell Therapy Centre of Excellence Launched at MHTP

A Cell Therapies Platform, incorporating the international biotechnology company’s Miltenyi Biotec Cell Therapy Centre of Excellence was officially launched at the Monash Health Translation Precinct (MHTP) in late August. “Specifically designed to underpin clinical translation of cell therapies and regenerative medicine, the establishment of the Cell Therapies Platform is a major new initiative within the precinct,” said

Read More
01 Sep

Could Nanotherapeutics Provide The Silver Bullet To Cure Cancer?

  While research of nano-sized particles in medical treatment is still in its early days, Dr Mohd Ezharul Hoque Chowdhury, Associate Professor of Biomedical Sciences at the Jeffrey Cheah School of Medicine  and Health Sciences, Monash University Malaysia, is currently exploring that possibility. Dr Ezharul has pioneered the development of pH-sensitive inorganic nanoparticles as smart tools

Read More
Page 7 of 10« First...56789...Last »